PortfoliosLab logoPortfoliosLab logo
ACVA vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ACVA vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ACV Auctions Inc. (ACVA) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ACVA achieves a -27.56% return, which is significantly lower than ABBV's -3.41% return.


ACVA

1D
-8.07%
1M
9.62%
YTD
-27.56%
6M
-26.46%
1Y
-64.44%
3Y*
-30.73%
5Y*
-26.01%
10Y*

ABBV

1D
0.80%
1M
4.31%
YTD
-3.41%
6M
-4.15%
1Y
19.73%
3Y*
20.88%
5Y*
18.44%
10Y*
17.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ACVA vs. ABBV - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ACVA
ACV Auctions Inc.
-27.56%-62.87%42.57%84.53%-56.42%-39.71%
ABBV
AbbVie Inc.
-3.41%33.08%18.86%-0.23%24.01%36.09%

Correlation

The correlation between ACVA and ABBV is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (All Time)
Calculated using the full available price history since Mar 25, 2021

0.01

Fundamentals

Market Cap

ACVA:

$1.01B

ABBV:

$385.19B

EPS

ACVA:

-$0.36

ABBV:

$2.05

PS Ratio

ACVA:

1.28

ABBV:

6.13

PB Ratio

ACVA:

2.34

ABBV:

14.01

Total Revenue (TTM)

ACVA:

$781.10M

ABBV:

$62.82B

Gross Profit (TTM)

ACVA:

$496.54M

ABBV:

$46.15B

EBITDA (TTM)

ACVA:

-$10.72M

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ACVA vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACVA
ACVA Risk / Return Rank: 88
Overall Rank
ACVA Sharpe Ratio Rank: 77
Sharpe Ratio Rank
ACVA Sortino Ratio Rank: 77
Sortino Ratio Rank
ACVA Omega Ratio Rank: 55
Omega Ratio Rank
ACVA Calmar Ratio Rank: 88
Calmar Ratio Rank
ACVA Martin Ratio Rank: 1313
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 6262
Overall Rank
ABBV Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6060
Sortino Ratio Rank
ABBV Omega Ratio Rank: 5959
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6363
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACVA vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ACV Auctions Inc. (ACVA) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ACVAABBVDifference

Sharpe ratio

Return per unit of total volatility

-0.90

0.83

-1.73

Sortino ratio

Return per unit of downside risk

-1.31

1.30

-2.60

Omega ratio

Gain probability vs. loss probability

0.80

1.16

-0.36

Calmar ratio

Return relative to maximum drawdown

-0.86

1.14

-2.00

Martin ratio

Return relative to average drawdown

-1.25

2.57

-3.83

ACVA vs. ABBV - Sharpe Ratio Comparison

The current ACVA Sharpe Ratio is -0.90, which is lower than the ABBV Sharpe Ratio of 0.83. The chart below compares the historical Sharpe Ratios of ACVA and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ACVAABBVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.90

0.83

-1.73

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.43

0.81

-1.24

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.68

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.46

0.73

-1.19

Drawdowns

ACVA vs. ABBV - Drawdown Comparison

The maximum ACVA drawdown since its inception was -88.80%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ACVA and ABBV.


Loading charts...

Drawdown Indicators


ACVAABBVDifference

Max Drawdown

Largest peak-to-trough decline

-88.80%

-45.09%

-43.71%

Max Drawdown (1Y)

Largest decline over 1 year

-75.43%

-17.32%

-58.11%

Max Drawdown (3Y)

Largest decline over 3 years

-82.09%

-20.74%

-61.35%

Max Drawdown (5Y)

Largest decline over 5 years

-84.16%

-21.92%

-62.24%

Max Drawdown (10Y)

Largest decline over 10 years

-45.09%

Current Drawdown

Current decline from peak

-84.31%

-9.04%

-75.27%

Average Drawdown

Average peak-to-trough decline

-59.90%

-10.73%

-49.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

51.38%

7.69%

+43.69%

Volatility

ACVA vs. ABBV - Volatility Comparison

ACV Auctions Inc. (ACVA) has a higher volatility of 27.00% compared to AbbVie Inc. (ABBV) at 5.42%. This indicates that ACVA's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ACVAABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.00%

5.42%

+21.58%

Volatility (6M)

Calculated over the trailing 6-month period

47.97%

17.61%

+30.36%

Volatility (1Y)

Calculated over the trailing 1-year period

71.88%

23.96%

+47.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.75%

22.84%

+37.91%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.50%

25.74%

+34.76%

Dividends

ACVA vs. ABBV - Dividend Comparison

ACVA has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.10%.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
3.10%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
ACVA
ACV Auctions Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ACVA vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between ACV Auctions Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
204.19M
15.00B
(ACVA) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

ACVA vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between ACV Auctions Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20222023202420252026
60.9%
83.5%
Portfolio components
ACVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ACV Auctions Inc. reported a gross profit of 124.37M and revenue of 204.19M. Therefore, the gross margin over that period was 60.9%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

ACVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ACV Auctions Inc. reported an operating income of -9.24M and revenue of 204.19M, resulting in an operating margin of -4.5%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

ACVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ACV Auctions Inc. reported a net income of -10.89M and revenue of 204.19M, resulting in a net margin of -5.3%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


ACVA and ABBV have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ACVA has higher volatility (27.00%) compared to ABBV (5.42%). In terms of maximum drawdown, ACVA dropped -88.80% vs ABBV's -45.09%.

ABBV currently has the higher Sharpe Ratio (0.83 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ACVA and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer